Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 95 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
941 12.0 months Metastatic Melanoma 5 Biologic therapy
Chemotherapy
Mayo Clinic United States 1/2009
Treatment Details: Patients: This phase II trial involved 53 patients with metastatic melanoma. Of these, 62.3% were male and the median age was 55 years old (range 30-84). Treatments: Patients in this s
 
942 12.0 months Hepatocellular carcinoma 3 Biologic therapy
Hormone
‘‘San Giovanni di Dio’’ Hospital Italy 10/2010
Treatment Details: Patients: This phase II study involved 50 patients with hepatocellular carcinoma. The median patient age was 67.5 years and 86% of the patients were male. Treatment: Patients were trea
 
943 12.0 months Metastatic breast cancer 4 Chemotherapy
M.D. Anderson Cancer Center United States 6/2007
Treatment Details: Patients: This phase II study involved 55 women with metastatic breast cancer. They ranged in age from 37 to 76 years. They were divided into two groups; those who had previous treatment
 
944 12.0 months Metastatic breast cancer 5 Chemotherapy
Metaxa Cancer Hospital Greece 10/2007
Treatment Details: Patients: This phase II study involved 71 women with metastatic breast cancer. They all had disease progression after being treated with anthracycline-based therapy. The median age was 55
 
945 12.0 months Newly diagnosed GBM 5 Chemotherapy
Radiation
Institut Claudius Regaud France 8/2007
Treatment Details: Patients: This phase I study involved 13 patients with newly diagnosed glioblastoma multiforme that had not received any treatment except for biopsy or surgery. There were 8 men and 5 wome
 
946 12.0 months metastatic breast cancer (over 65) 3 Chemotherapy
Mayo Clinic United States 4/2006
Treatment Details: Patients: This phase II study involved 25 patients (median age 73) with metastatic breast cancer. All patients were 65 years og age or over. Treatment: The treatment consisted of one ch
 
947 12.0 months Advanced NSCLC 4 Chemotherapy
International Medical Center of Japan Japan 12/2005
Treatment Details: Patients: This Phase I/II study involved 77 patients with advanced non-small-cell lung cancer. All patients had not received previous chemotherapy. 56 were men and 21 were women. Ages ra
 
948 12.0 months Advanced NSCLC 4 Chemotherapy
University of Verona Italy 7/2006
Treatment Details: Patients: This Phase II trial involved a total of 44 patients with advanced non-small-cell lung cancer. There were 36 men and 8 women. The median age was 70. Treatment: The treatment co
 
949 12.0 months metastatic melanoma 4 Chemotherapy
Istituto Nazionale per lo Studio e la Curra dei Tumori Italy 2/2006
Treatment Details: Patients: This phase III study involved 151 patients with metastatic melanoma. Patients were divided into two groups: Group A had 75 patients and Group B had 76 patients. The median age f
 
950 12.0 months Newly diagnosed GBM 5 Chemotherapy
Radiation
Mayo Clinic United States 8/2006
Treatment Details: Patients: This phase III study involved 401 patients with newly diagnosed glioblastoma multiforme. The median age was 56 years, and the majority (over 60%) were men. Treatment: The patie
 
Page 95 of 187  | Previous Page  | Next Page